# DOXEPIN HYDROCHLORIDE
> **ANDA213919** · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARMA CANADA · Approved 2026-04-28
## Drug
- **FDA Application Number:** ANDA213919
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOXEPIN HYDROCHLORIDE
- **Generic name:** Doxepin Hydrochloride
- **Active ingredients:** DOXEPIN HYDROCHLORIDE
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** SUN PHARMA CANADA
- **First approval:** 2026-04-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213919)
---
*AI Analytics · CC0 1.0*